SE175402C1 - - Google Patents
Info
- Publication number
- SE175402C1 SE175402C1 SE175402DA SE175402C1 SE 175402 C1 SE175402 C1 SE 175402C1 SE 175402D A SE175402D A SE 175402DA SE 175402 C1 SE175402 C1 SE 175402C1
- Authority
- SE
- Sweden
- Prior art keywords
- methyl
- ester
- alkyl
- acid
- solution
- Prior art date
Links
- 238000000034 method Methods 0.000 claims description 7
- 230000003444 anaesthetic effect Effects 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- 239000003589 local anesthetic agent Substances 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 4
- 229910052794 bromium Inorganic materials 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 4
- 150000001558 benzoic acid derivatives Chemical class 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 150000003053 piperidines Chemical class 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 1
- 239000011591 potassium Substances 0.000 claims 1
- 229910052700 potassium Inorganic materials 0.000 claims 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 45
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 39
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 30
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 29
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 14
- -1 ester piperidine derivatives Chemical class 0.000 description 12
- 238000009835 boiling Methods 0.000 description 11
- 238000002844 melting Methods 0.000 description 11
- 230000008018 melting Effects 0.000 description 11
- 206010002091 Anaesthesia Diseases 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 230000037005 anaesthesia Effects 0.000 description 9
- 150000002148 esters Chemical class 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 9
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 9
- 239000003610 charcoal Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000001704 evaporation Methods 0.000 description 7
- 229960004919 procaine Drugs 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- RFPVXZWXDPIKSD-UHFFFAOYSA-N [2-(diethylamino)-4-methylpentyl] 4-aminobenzoate;methanesulfonic acid Chemical compound CS(O)(=O)=O.CCN(CC)C(CC(C)C)COC(=O)C1=CC=C(N)C=C1 RFPVXZWXDPIKSD-UHFFFAOYSA-N 0.000 description 6
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 238000004821 distillation Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 4
- ZEYHEAKUIGZSGI-UHFFFAOYSA-N 4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-N 0.000 description 4
- YFDUWSBGVPBWKF-UHFFFAOYSA-N Butyl salicylate Chemical compound CCCCOC(=O)C1=CC=CC=C1O YFDUWSBGVPBWKF-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- CUONSCCYXXFZPO-UHFFFAOYSA-N (1-methylpiperidin-4-yl) 4-butoxybenzoate Chemical compound C1=CC(OCCCC)=CC=C1C(=O)OC1CCN(C)CC1 CUONSCCYXXFZPO-UHFFFAOYSA-N 0.000 description 3
- BAUWRHPMUVYFOD-UHFFFAOYSA-N 1-methylpiperidin-4-ol Chemical compound CN1CCC(O)CC1 BAUWRHPMUVYFOD-UHFFFAOYSA-N 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Natural products OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 235000010233 benzoic acid Nutrition 0.000 description 3
- 230000032050 esterification Effects 0.000 description 3
- 238000005886 esterification reaction Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- AROAGUCPXICSGW-UHFFFAOYSA-N (1-methylpiperidin-4-yl) 4-(butylamino)benzoate Chemical compound C1=CC(NCCCC)=CC=C1C(=O)OC1CCN(C)CC1 AROAGUCPXICSGW-UHFFFAOYSA-N 0.000 description 2
- NLNRFKWXAJZLTD-UHFFFAOYSA-N (1-methylpiperidin-4-yl) 4-ethoxybenzoate Chemical compound C1=CC(OCC)=CC=C1C(=O)OC1CCN(C)CC1 NLNRFKWXAJZLTD-UHFFFAOYSA-N 0.000 description 2
- OTLNPYWUJOZPPA-UHFFFAOYSA-N 4-nitrobenzoic acid Chemical compound OC(=O)C1=CC=C([N+]([O-])=O)C=C1 OTLNPYWUJOZPPA-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- QRFOLKDOJLEYNQ-UHFFFAOYSA-N CN1CCC(CC1)OC(C1=CC=C(C=C1)NCCOC)=O Chemical compound CN1CCC(CC1)OC(C1=CC=C(C=C1)NCCOC)=O QRFOLKDOJLEYNQ-UHFFFAOYSA-N 0.000 description 2
- XHKOMWDRDFDUOO-UHFFFAOYSA-N CN1CCC(CC1)OC(C=1C(NCCCC)=CC=CC1)=O Chemical compound CN1CCC(CC1)OC(C=1C(NCCCC)=CC=CC1)=O XHKOMWDRDFDUOO-UHFFFAOYSA-N 0.000 description 2
- XTEGARKTQYYJKE-UHFFFAOYSA-M Chlorate Chemical compound [O-]Cl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-M 0.000 description 2
- 241000408659 Darpa Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 229940053973 novocaine Drugs 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- ASAQSVYQBBYRDA-UHFFFAOYSA-N (1-methylpiperidin-4-yl) 2-chlorobenzoate Chemical compound C1CN(C)CCC1OC(=O)C1=CC=CC=C1Cl ASAQSVYQBBYRDA-UHFFFAOYSA-N 0.000 description 1
- YJLYLEFICAFJLC-UHFFFAOYSA-N (1-methylpiperidin-4-yl) 4-aminobenzoate Chemical compound C1CN(C)CCC1OC(=O)C1=CC=C(N)C=C1 YJLYLEFICAFJLC-UHFFFAOYSA-N 0.000 description 1
- WHKSLVUVVFGDFB-UHFFFAOYSA-N (1-methylpiperidin-4-yl) 4-chlorobenzoate Chemical compound C1CN(C)CCC1OC(=O)C1=CC=C(Cl)C=C1 WHKSLVUVVFGDFB-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- MPPPKRYCTPRNTB-UHFFFAOYSA-N 1-bromobutane Chemical compound CCCCBr MPPPKRYCTPRNTB-UHFFFAOYSA-N 0.000 description 1
- IOHPVZBSOKLVMN-UHFFFAOYSA-N 2-(2-phenylethyl)benzoic acid Chemical group OC(=O)C1=CC=CC=C1CCC1=CC=CC=C1 IOHPVZBSOKLVMN-UHFFFAOYSA-N 0.000 description 1
- DHBHUGJZAZYELM-UHFFFAOYSA-N 2-(butylamino)benzoic acid Chemical compound CCCCNC1=CC=CC=C1C(O)=O DHBHUGJZAZYELM-UHFFFAOYSA-N 0.000 description 1
- YCCRFDDXAVMSLM-UHFFFAOYSA-N 4-(butylamino)benzoic acid Chemical compound CCCCNC1=CC=C(C(O)=O)C=C1 YCCRFDDXAVMSLM-UHFFFAOYSA-N 0.000 description 1
- RKIDDEGICSMIJA-UHFFFAOYSA-N 4-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C=C1 RKIDDEGICSMIJA-UHFFFAOYSA-N 0.000 description 1
- XLWQUESMILVIPR-UHFFFAOYSA-N 4-ethoxybenzoyl chloride Chemical compound CCOC1=CC=C(C(Cl)=O)C=C1 XLWQUESMILVIPR-UHFFFAOYSA-N 0.000 description 1
- SKDHHIUENRGTHK-UHFFFAOYSA-N 4-nitrobenzoyl chloride Chemical compound [O-][N+](=O)C1=CC=C(C(Cl)=O)C=C1 SKDHHIUENRGTHK-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- FNAYJLTWWSHTPO-UHFFFAOYSA-N Cl.C(CCC)NC1=CC=C(C(=O)Cl)C=C1 Chemical compound Cl.C(CCC)NC1=CC=C(C(=O)Cl)C=C1 FNAYJLTWWSHTPO-UHFFFAOYSA-N 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 235000017349 Tetrapleura tetraptera Nutrition 0.000 description 1
- 240000008374 Tetrapleura tetraptera Species 0.000 description 1
- 150000007513 acids Chemical group 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- MXMOTZIXVICDSD-UHFFFAOYSA-N anisoyl chloride Chemical compound COC1=CC=C(C(Cl)=O)C=C1 MXMOTZIXVICDSD-UHFFFAOYSA-N 0.000 description 1
- 150000001559 benzoic acids Chemical group 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- FGKAJIQTQRCTAU-UHFFFAOYSA-N ethyl 4-(2-methoxyethylamino)benzoate Chemical compound CCOC(=O)C1=CC=C(NCCOC)C=C1 FGKAJIQTQRCTAU-UHFFFAOYSA-N 0.000 description 1
- GTXRSQYDLPYYNW-UHFFFAOYSA-N ethyl 4-(butylamino)benzoate Chemical compound CCCCNC1=CC=C(C(=O)OCC)C=C1 GTXRSQYDLPYYNW-UHFFFAOYSA-N 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- PUHCYTHGLBCWEA-UHFFFAOYSA-N methyl 4-butoxybenzoate Chemical compound CCCCOC1=CC=C(C(=O)OC)C=C1 PUHCYTHGLBCWEA-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 210000000715 neuromuscular junction Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE175402T |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE175402C1 true SE175402C1 (da) | 1961-01-01 |
Family
ID=41964586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE175402D SE175402C1 (da) |
Country Status (1)
| Country | Link |
|---|---|
| SE (1) | SE175402C1 (da) |
-
0
- SE SE175402D patent/SE175402C1/sv unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU191301B (en) | Process for preparing 1-/hydroxy-methyl/-1,6,7,11b-tetrahydro-2h,4h-/1,3/-oxazino- or -thiazino/4,3-a/isoquinoline -derivatives | |
| SE175402C1 (da) | ||
| SE461654B (sv) | Saett att framstaella racemiska cis- och/eller trans-apovinkaminsyraestrar | |
| FI85491C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara fosfonsyraderivat. | |
| Connor et al. | Synthesis of the 3a, 8a-dihydrofuro [2, 3-b] benzofuran-2 (3H)-one and 1, 3, 3a, 8a-tetrahydro-2H-benzofuro [2, 3-b] pyrrol-2-one ring systems from 4-formylcoumarin via acyllactone and iminolactone rearrangements | |
| US2956059A (en) | Ester-like pipemdine derivatives | |
| US2934535A (en) | Z-amino-x-trifluoromethylanilino-s | |
| US2778829A (en) | New 5:6-dihydro-benzo (c) cinnoline derivatives and a process for their preparation | |
| US2296167A (en) | Acyl derivatives of vitamin b6 and process of making the same | |
| US4732906A (en) | Dioxolobenzizoxazole derivatives | |
| US3255189A (en) | Alkyl 7, 8-dihydroxy-2-oxo-2h-1, 4-benzoxazin-3-acetates | |
| US3917595A (en) | 4-Methyl-{60 ,2-diphenyl-5-pyrimidinemethanol | |
| KR800001551B1 (ko) | 환상 화합물의 제조방법 | |
| US2660582A (en) | Quaternary nicotinic acid amide derivatives and production thereof | |
| US3394140A (en) | Diethyl ester of 4-phenyl-1, 4-piperidinedicarboxylic acid | |
| SE201895C1 (da) | ||
| SE177468C1 (da) | ||
| SE204297C1 (da) | ||
| SE204141C1 (da) | ||
| GB2068374A (en) | Basic ethers of 7-oxo-7h-benzo(c)fluorene | |
| SE184698C1 (da) | ||
| SE445347B (sv) | 8-metoxi-3-fenyl-5-metylpropargylaminometyl-1,2-bensopyron med antikonvulsiv aktivitet, forfarande for framstellning derav samt farmaceutiska kompositioner innehallande nemnda forening | |
| Schreiber et al. | Anomalous Mutarotation of Salts of Reychler's Acid. II. Ketimine Formation from Amine Salts of d-Camphor-10-sulfonic Acid | |
| SE176043C1 (da) | ||
| CH599227A5 (en) | Benzothiadiazine-fluorophenyl-oxo-butyl-piperidine oxide deriv. prepn. |